Professional Documents
Culture Documents
Comparison and Review of Indirect Myofascial Release Therapy, IASTM, and ART To Inform CDM
Comparison and Review of Indirect Myofascial Release Therapy, IASTM, and ART To Inform CDM
Comparison and Review of Indirect Myofascial Release Therapy, IASTM, and ART To Inform CDM
Therapeutic effects differ between MFR and in ROM were found after treatment using IASTM and
IASTM.13,43 Controlled inflammatory responses are MFR.5,18,39,43,55 There is evidence to support the short-
activated using IASTM.5 Indirect MFR and ART do not term outcomes of MFR14–16 and IASTM,29,39,42,45 but
intend to elicit an inflammatory response.4 All three limited evidence exists for the long-term benefits of
interventions use similar application directions in a these treatment protocols. Future research must be
multidimensional plane to correct fascial disfigure- conducted to track long-term patient outcomes and
ment.2,3,5,12,61 Certification and training programs for generate evidence to support or refute long-term use
MFR, IASTM, and ART differ slightly and are encour- of these interventions in particular clinical scenarios.
aged for clinicians to apply these therapies correctly. Indirect MFR, IASTM, and ART share similarities
MFR therapy training is recommended, although not and have differences in theoretical bases. ART requires
required, for clinicians. IASTM certification is required active movement from the patient to achieve releases
by certain IASTM companies (i.e., Graston Technique),38 of soft tissue adhesions.3 IASTM offers a mechanical
while others recommend but do not require it. ART advantage through external instrumentation use to
certification requires potential clinicians to be licensed initiate a local inflammatory response to promote
health care professionals with malpractice insurance new collagen formation and fibroblast formation in
and within the appropriate scope of practice to perform tissues.5,34 Indirect MFR is believed to offer morpholog-
soft tissue treatment.5 ical changes in connective and neuromuscular tissue
The outcome measures most commonly used with and may optimize fibroblast activity through force
each therapy demonstrate improvements in pain and application in ways similar to IASTM.2,9 Randomized
ROM (Table 1).4,5,14–17,39,43,56 Immediate improvements control trials are limited, but current research indicates